Gengraf
Product Images NDC 0074-0541

7 FDA label images from Abbvie Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gengraf (NDC 0074-0541). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure For Cyclosporine Usp Is (Gengraf Capsules Spl 01)

The Chemical Structure For Cyclosporine Usp Is (Gengraf Capsules Spl 01)
Chemical structure diagram showing molecular details with atoms and bonds, labeled with several amino acid abbreviations including MeVal, MeLeu, D-Ala, Ala, and others, along with the molecular formula C62H111N11O12 and molecular weight 1202.61. This likely represents the active ingredient related to Gengraf.*
FDA Label Image

Graph (Gengraf Capsules Spl 02)

Graph (Gengraf Capsules Spl 02)
A bar graph titled 'ACR Responders Randomized' comparing percentages of responders across different treatment groups including CsA (Cyclospone Modified), Mtx, and placebo. The graph shows percentages on the vertical axis from 0% to 50%, with multiple bars grouped by treatment conditions, displaying p-values above some groups indicating statistical comparisons versus placebo or other treatments.*
FDA Label Image

No Image (Gengraf Capsules Spl 03)

FDA Label Image

No Image (Gengraf Capsules Spl 04)

FDA Label Image

Ndc 0074–3108–32 30 Capsules Gengraf®capsules (cyclosporine Capsules, Usp [modified]) 25 mg Warning: Gengraf®capsules (cyclosporine Capsules, Usp [modified]) Is Not Bioequivalent To Sandimmune® Soft Gelatin Capsules (cyclosporine Capsules, Usp). Do Not Use Interchangeably Without A Physician’s Supervision. Abbvie Rx Only (Gengraf Capsules Spl 05)

Ndc 0074–3108–32 30 Capsules Gengraf®capsules (cyclosporine Capsules, Usp [modified]) 25 mg Warning: Gengraf®capsules (cyclosporine Capsules, Usp [modified]) Is Not Bioequivalent To Sandimmune® Soft Gelatin Capsules (cyclosporine Capsules, Usp). Do Not Use Interchangeably Without A Physician’s Supervision. Abbvie Rx Only (Gengraf Capsules Spl 05)
Gengraf Capsules 25 mg packaging label for cyclosp I orine capsules, USP (Modified) by AbbVie Inc. The label states 30 capsules per bottle and includes warnings, inactive ingredients, usage instructions, and storage conditions. The label also emphasizes not to interchange with Sandimmune Soft Gelatin Capsules and instructs on capsule removal from the blister.*
FDA Label Image

No Image (Gengraf Capsules Spl 06)

FDA Label Image

Ndc 0074–3109–32 30 Capsules Gengraf®capsules (cyclosporine Capsules, Usp [modified]) 100 mg Warning: Gengraf®capsules (cyclosporine Capsules, Usp [modified]) Is Not Bioequivalent To Sandimmune® Soft Gelatin Capsules (cyclosporine Capsules, Usp). Do Not Use Interchangeably Without A Physician’s Supervision. Abbvie Rx Only (Gengraf Capsules Spl 07)

Ndc 0074–3109–32 30 Capsules Gengraf®capsules (cyclosporine Capsules, Usp [modified]) 100 mg Warning: Gengraf®capsules (cyclosporine Capsules, Usp [modified]) Is Not Bioequivalent To Sandimmune® Soft Gelatin Capsules (cyclosporine Capsules, Usp). Do Not Use Interchangeably Without A Physician’s Supervision. Abbvie Rx Only (Gengraf Capsules Spl 07)
Gengraf Capsules 100 mg carton label for cyclosporine capsules USP (modified), containing 30 capsules per bottle. The label features dosage strength, usage warnings, and handling instructions, and is produced by AbbVie Inc. The package includes a barcode and NDC number 0074-3109-32.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.